New Jersey man alleges Mushroom Wisdom falsely labels product

By Robbie Hargett | Feb 27, 2016

NEWARK, N.J. (Legal Newsline) – A New Jersey man is suing a mushroom supplements producer over claims it falsely advertises one of its products as able to cure brain disease.

Harold M. Hoffman, individually and for all others similarly situated, filed a class-action lawsuit Jan. 19 in the Superior Court of New Jersey against Mushroom Wisdom, alleging violations of the New Jersey Consumer Fraud Act.

The suit states that Mushroom Wisdom markets, advertises, promotes, distributes and sells a dietary supplement known as Amyloban3399.

Mushroom Wisdom allegedly promotes the product as effective in the cure, mitigation, treatment or prevention of brain disease, including Alzheimer's disease.

The suit alleges Mushroom Wisdom's claims about the product are unsubstantiated and violate federal law, which prohibits the sale of all unapproved and uncleared products, including Amybolan, for the diagnosis, mitigation, prevention, treatment or cure of any disease.

Hoffman and others in the class seek treble damages, interests, attorney fees and other court costs. Hoffman is representing himself and the putative class.

The defendant filed to transfer the case to federal court because the plaintiff's claims arise under federal laws and there is diversity jurisdiction under the Class Action Fairness Act of 2005. It is represented by Richard D. Kraus of Hackensack, New Jersey and Peter A. Arhangelsky of Emord & Associates of Chandler, Arizona.

U.S. District Court for the District of New Jersey Case number 2:16-CV-00768-WJM-MF

Want to get notified whenever we write about U.S. District Court for the District of New Jersey ?

Sign-up Next time we write about U.S. District Court for the District of New Jersey, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.

Organizations in this Story

U.S. District Court for the District of New Jersey

More News

The Record Network